|
시장보고서
상품코드
2091888
탈회골기질 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 조직 유래별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Demineralized Bone Matrix Market Size, Share, and Growth Analysis, By Product Type (Putty, Gel), By Tissue Source, By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 탈회골기질(DBM) 시장 규모는 2024년에 13억 3,000만 달러로 평가되며, 2025년 14억 2,000만 달러에서 2033년까지 23억 6,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 6.6%로 성장할 것으로 전망되고 있습니다.
세계의 탈회골기질(DBM) 시장은 주로 정형외과 및 치과 치료에서 골 재생을 촉진하는 데 중요한 역할을 하고 있으므로 인상적인 성장을 달성하고 있습니다. 척추 고정술에 대한 수요가 증가하는 가운데, 자가골 이식에 수반되는 합병증을 최소화할 수 있다는 장점 덕분에 외과의사들은 DBM을 선호하여 채택하고 있습니다. 특히 가공 방식에 대한 기술의 발전으로 인해 DBM의 안전성과 유효성이 향상되었으며, 그 임상적 중요성이 더욱 커지고 있습니다. 고령화의 진행과 골다공증성 골절의 증가가 맞물리면서, 의료제도가 효율적인 치료 대안을 모색하는 가운데 수요는 더욱 높아지고 있습니다. AI를 활용한 자동화의 등장으로 생산 효율과 품질의 일관성이 향상되었으며, 제조업체는 시장의 수요에 신속하게 대응하고 운영 비용을 절감할 수 있게 되었습니다. 그 결과, 의료 종사자들에게 고품질의 골이식편 공급이 가속화될 것입니다.
전 세계 탈회골기질 시장의 성장 요인
전 세계에서 정형외과 및 외상 수술 건수가 증가함에 따라 골이식 대체재에 대한 안정적인 수요가 발생하고 있습니다. 이에 따라 의료진과 외과의사들은 자가골 이식을 대체할 수 있는 효과적인 대안으로서 탈회골기질를 점점 더 많이 활용하고 있습니다. 이러한 추세는 탈회골기질가 자연적인 골 치유를 촉진하고, 채취 부위와 관련된 합병증을 최소화하는 능력에 기반을 두고 있으며, 궁극적으로 환자의 회복을 촉진하는 결과로 이어집니다. 그 결과, 의료 종사자들은 수술 현장에서 DBM 제품을 점차 도입하고 있으며, 선진국과 신흥 시장을 막론하고 다양한 의료 환경에서 시장 성장을 주도하고 있습니다. 또한 DBM의 입증된 안전성 프로파일은 복잡한 재건 수술에 대한 적용을 더욱 촉진하고, 시장 전체의 확대에 기여하고 있습니다.
세계 탈회골기질(DBM) 시장의 제약 요인
전 세계 탈회골기질(DBM) 시장은 지역별로 상이한 생체 이식재 관련 규제 체계로 인해 큰 과제에 직면해 있습니다. 제조사는 복잡한 서류 작성, 임상 검증 절차 및 규정 준수 요건을 충족해야 하며, 이로 인해 승인까지의 기간이 길어지고 개발 비용이 증가할 가능성이 있습니다. 이러한 복잡성으로 인해 중소기업의 시장 진입이 저해되고, 결과적으로 구할 수 있는 DBM 제품의 선택지가 제한되는 경향이 있습니다. 또한 특정 지역의 엄격한 안전 기준이 이러한 제품의 보급률을 저해할 가능성이 있으며, 임상적 수요가 높음에도 불구하고 시장 성장을 제한하는 요인이 되고 있습니다. 또한 상장 후 광범위한 모니터링이 필요하게 됨에 따라 사업 운영에 추가적인 부담이 가중되고, 혁신적인 솔루션의 도입이 지연되어 결국 시장 성장을 저해하게 됩니다.
세계 탈회골기질 시장의 동향
전 세계 탈회골기질 시장에서는 정밀 의학의 발전을 원동력으로 삼아, 맞춤형 동종 이식편 솔루션으로의 큰 흐름이 나타나고 있습니다. 의료 분야에서 맞춤형 치료 접근법이 점점 더 중요시됨에 따라 환자의 유전자 프로파일이나 특정 결손 부위의 특성에 맞춘 맞춤형 탈회골기질 제제에 대한 수요가 증가하고 있습니다. 이러한 추세에 따라 제조사들은 첨단 가공 기술 및 바이오마커 분석 개발에 주력하게 되었으며, 그 결과 이식편의 생착률 향상, 합병증 최소화, 그리고 환자의 회복 기간 단축으로 이어지고 있습니다. 그 결과, 맞춤형 솔루션은 정형외과 및 척추 재건 분야의 시장 성장을 이끄는 필수적인 원동력이 되고 있으며, 궁극적으로는 다양한 의료 시스템에서 생물학적 치료법에 대한 임상의와 환자의 신뢰를 높이는 데 기여하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 탈회골기질 시장 규모 : 제품 유형별
세계의 탈회골기질 시장 규모 : 조직 유래별
세계의 탈회골기질 시장 규모 : 용도별
세계의 탈회골기질 시장 규모 : 최종사용자별
세계의 탈회골기질 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.27Global Demineralized Bone Matrix Market size was valued at USD 1.33 Billion in 2024 and is poised to grow from USD 1.42 Billion in 2025 to USD 2.36 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026-2033).
The global market for demineralized bone matrix (DBM) is experiencing significant growth, primarily driven by its vital role in accelerating bone regeneration in orthopedic and dental procedures. Increasing demand for spinal fusion surgeries is prompting surgeons to prefer DBM due to its effectiveness in minimizing complications associated with autograft harvesting. Technological advancements, particularly in processing methods, have improved the safety and potency of DBM, reinforcing its clinical significance. The aging population, coupled with a rise in osteoporotic fractures, further galvanizes demand as healthcare systems seek efficient treatment alternatives. The emergence of AI-driven automation enhances production efficiency and consistency, enabling manufacturers to respond swiftly to market needs and reduce operational costs, ultimately accelerating the supply of high-quality bone grafts to healthcare providers.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Demineralized Bone Matrix market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Demineralized Bone Matrix Market Segments Analysis
Global demineralized bone matrix market is segmented by product type, tissue source, application, end user and region. Based on product type, the market is segmented into Putty, Gel, Paste, Fiber, Sponge, Strips and Sheets and Others. Based on tissue source, the market is segmented into Allograft Cortical Bone, Allograft Cancellous Bone, Combined Allograft and Synthetics and Others. Based on application, the market is segmented into Spinal Fusion, Dental Procedures, Joint Reconstruction, Trauma Fracture Management, Foot and Ankle Reconstruction, Craniomaxillofacial Surgery and Others. Based on end user, the market is segmented into Hospitals, Specialty Orthopedic Clinics, Dental Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Demineralized Bone Matrix Market
The increasing prevalence of orthopedic and trauma surgeries globally generates a consistent demand for bone graft substitutes, leading healthcare providers and surgeons to increasingly utilize demineralized bone matrix as a viable alternative to autografts. This trend is fueled by the matrix's capacity to promote natural bone healing and minimize complications associated with donor site harvesting, ultimately facilitating improved patient recovery. As a result, healthcare professionals are progressively integrating DBM products into their surgical practices, driving market growth across a variety of healthcare environments, both in developed nations and emerging markets. Moreover, the established safety profile of DBM further incentivizes its adoption for intricate reconstruction procedures, contributing to the overall expansion of the market.
Restraints in the Global Demineralized Bone Matrix Market
The global Demineralized Bone Matrix (DBM) market faces significant challenges due to the diverse regulatory frameworks surrounding biologic grafts in different regions. Manufacturers must navigate complex documentation, clinical validation processes, and compliance requirements, which can extend approval times and inflate development costs. This complexity tends to deter smaller companies from entering the market, resulting in a restricted range of DBM products available. Moreover, stringent safety standards in certain areas may hinder the adoption rates of these products, limiting market growth despite strong clinical demand. Additionally, the necessity for extensive post-marketing surveillance further burdens operations and slows the introduction of innovative solutions, ultimately stifling market growth.
Market Trends of the Global Demineralized Bone Matrix Market
The Global Demineralized Bone Matrix market is experiencing a significant trend towards personalized allograft solutions driven by advancements in precision medicine. As healthcare increasingly emphasizes individualized treatment approaches, there is growing demand for customized demineralized bone matrix formulations that align with patients' genetic profiles and specific defect characteristics. This trend encourages manufacturers to focus on developing advanced processing techniques and biomarker analytics, leading to improved graft integration rates, minimize complications, and enhance patient recovery times. Consequently, personalized solutions are becoming essential catalysts for market growth in orthopedic and spinal reconstruction, ultimately fostering heightened clinician-patient trust in biologic therapies across diverse healthcare systems.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Demineralized Bone Matrix Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Putty
- Gel
- Paste
- Fiber
- Demineralized Cortical Fibers
- Interlocking Fiber Matrix
- Sponge
- Strips and Sheets
- Others
Global Demineralized Bone Matrix Market Size by Tissue Source & CAGR (2026-2033)
- Market Overview
- Allograft Cortical Bone
- Allograft Cancellous Bone
- Combined Allograft and Synthetics
- Others
Global Demineralized Bone Matrix Market Size by Application & CAGR (2026-2033)
- Market Overview
- Spinal Fusion
- Dental Procedures
- Joint Reconstruction
- Trauma Fracture Management
- Foot and Ankle Reconstruction
- Craniomaxillofacial Surgery
- Others
Global Demineralized Bone Matrix Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Specialty Orthopedic Clinics
- Dental Clinics
- Ambulatory Surgical Centers
- Others
Global Demineralized Bone Matrix Market Size & CAGR (2026-2033)
- North America (Product Type, Tissue Source, Application, End User)
- US
- Canada
- Europe (Product Type, Tissue Source, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Tissue Source, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Tissue Source, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Tissue Source, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orthofix Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enovis Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MTF Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AlloSource
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Community Tissue Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xtant Medical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LifeNet Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biocomposites Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Straumann Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arthrex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Globus Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tissue Regenix Group plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RTI Surgical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Berkeley Advanced Biomaterials, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
